Verve Therapeutics, Inc. (VERV) Social Stream
Verve Therapeutics Inc (VERV) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VERV.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 178 days, VERV's average price target has gone down $15.22.
Over the past 35 weeks, VERV's average upside potential has been 61.59%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VERV Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
VERV's average broker recommendation rating improved by 0.09 over the prior 120 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VERV as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Verve Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 533.26% of them.
- In terms of how Verve Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -365.99% of that group.
- In terms of how Verve Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 476.35% of that group.
- In terms of how Verve Therapeutics Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 250.57% of that group.
Is VERV a Buy, Hold or Sell? See the POWR Ratings now!